Towards precision secondary prevention after myocardial infarction and stroke with glucagon-like peptide-1 receptor agonists - Top-Institutions - MDSpire

Towards precision secondary prevention after myocardial infarction and stroke with glucagon-like peptide-1 receptor agonists

  • By

  • Fariba Ahmadizar

  • Joline W J Beulens

  • January 29, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Clinical Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Neurology

  • #3

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Neurology

  • #4

    Imperial College London
    Imperial College London

    London, N/A

    Key Differentiators

    • Cardiovascular Medicine
    • Endocrinology
    • Epidemiology

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Clinical Epidemiology

Original Source(s)

Towards precision secondary prevention after myocardial infarction and stroke with glucagon-like peptide-1 receptor agonists

  • by Fariba Ahmadizar, Joline W J Beulens

  • January 29, 2026

Related Content

An explainable streaming early identification model for early neurological deterioration based on coordinated fusion of ECG waveforms and vital signs

Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies

A systematic review and meta-analysis of the effects of exercise training on dysfunction in acute, subacute, and chronic stroke patients